In summary, RNK06138 is a potent, tumor-selective, and efficacious chaperone-mediated ERK5 degrader that could be used in tumor-targeted therapy
Van Konynenburg, RA (March 4, 2012)
L-NAME and BPC 157 regimens and dose application were adjusted according to our previous studies (reviewed Alternatively, to perceive the effect of the given medication itself (without L-NAME), rats received only BPC 157 (total dose 10 g/kg or 10 ng/kg as retrobulbar application in each eye, 1 g/0.1 ml saline/each eye, or 1 ng/0.1 ml saline/each eye) or only saline via retrobulbar application in each eye (0.1 ml/each eye) (as an additional control sham group) at the corresponding time point
Applied and Environmental Microbiology 68:1864-1871
Recalls & Warnings January 24, 2013 "Thermo Stimulating" Supplement Recalled -- Contained DMAA On January 23, 2013, Health Canada advised consumers not to use certain batches of Muscletech Hydroxystim capsules which were found to contain DMAA (1,3-dimethylamylamine) and have been recalled by their distributor